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Abstract: 
Accumulation of protein- and lipid-containing deposits external to the retinal pigment epithelium 
(RPE) is common in the aging eye, and has long been viewed as the hallmark of age-related 
macular degeneration (AMD). The cause for the accumulation and retention of molecules in the 
sub-RPE space, however, remains an enigma. Here we present fluorescence microscopy and 
x-ray diffraction evidence for the formation of small (0.5-20 micron diameter), hollow, 
hydroxyapatite (HAP) spherules in the Bruch’s membrane in human eyes. These spherules are 
distinct in form, placement, and staining from the well-known calcification of the elastin layer of 
the aging Bruch’s membrane. Secondary ion mass spectrometry (SIMS) imaging confirmed the 
presence of calcium phosphate in the spherules, and identified cholesterol enrichment in their 
core. Using HAP-selective fluorescent dyes we show that all types of sub-RPE deposits in the 
macula as well as in the periphery contain numerous HAP spherules. Immunohistochemical 
labeling for proteins characteristic of sub-RPE deposits, such as complement factor H, 
vitronectin, and amyloid beta, revealed that HAP spherules were coated with these proteins. 
HAP spherules were also found outside the sub-RPE deposits, ready to bind proteins at the 
RPE-choroid interface. Based on these results we propose a novel mechanism for the growth 
and possibly even the formation of sub-RPE deposits, namely that the deposit growth and 
formation begins with the deposition of insoluble HAP shells around naturally occurring 
cholesterol-containing extracellular lipid droplets at the RPE-choroid interface; proteins and 
lipids then attach to these shells, initiating or supporting the growth of sub-RPE deposits. 
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Significance Statement 
 
Proteins and lipids accumulating in deposits external to the RPE represent a barrier to metabolic 
exchange between the retina and the choroidal capillaries. With time, these deposits can lead to 
age-related macular degeneration (AMD), the most common cause of blindness in the elderly in 
the  developed  world.  It  remains  unclear  how  sub-RPE  deposits  are  initiated  and  grow  to 
clinically relevant features.  Using a combination of high resolution analytical techniques we 
found that tiny hydroxyapatite (bone mineral) spherules with cholesterol-containing cores are 
present in all examined sub-RPE deposits, providing a scaffold to which proteins adhere. If the 
spherules are important in initiating sub-RPE deposit formation this may provide attractive new 
approaches for early identification and treatment of AMD.   
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Introduction 
A major feature of the aging retina is the deposition of proteins(1)and lipids(2) external to the 
retinal pigment epithelium (RPE), leading to the formation of sub-RPE deposits that can be focal 
(drusen) or diffuse (basal linear and basal laminar deposits)(3, 4).  Sub-RPE deposits increase 
in  number  and  size  with  age,  and  are  believed  to  impair  metabolic  exchange  between  the 
choroidal blood circulation and the retina(5). This blockage of nutrient and waste flow to and 
from  the  highly  active  photoreceptors  is  widely  suspected  of  inducing  degeneration  of  the 
sensory  retina,  particularly  in  the  macula,  eventually  leading  to  age-related  macular 
degeneration. Due to this correlation between AMD and sub-RPE deposit formation, substantial 
effort has been devoted to determining the composition and origin of sub-RPE deposits, with a 
view to developing better diagnosis, prevention, and treatment for AMD(4). Although AMD does 
not necessarily follow the same course in all patients(6), it is acknowledged that progression of 
sub-RPE deposit formation is a major factor in a large proportion of cases. 
 
There is compelling evidence for the production and secretion of cholesterol-containing lipids 
and  lipoprotein  particles,  secreted  at  least  partly  by  the  RPE(7,  8),  that  are  recruited  and 
retained in the aging Bruch’s membrane(9-14). However, there is no unifying explanation of how 
and why proteins are recruited and retained at the RPE/choriocapillaris interface. Given the high 
degree of protein heterogeneity within sub-RPE deposits, it was puzzling why specific proteins, 
like beta amyloid or complement factor H, appear therein as hollow, spherule-like structures (15, 
16).  Here, we identify numerous hollow hydroxyapatite (HAP) spherules with lipid cores in all 
examined sub-RPE deposits, with proteins bound to the spherules’ surfaces. Individual HAP 
spherules are also present external to the RPE and we propose that these HAP spherules are 
involved in protein deposition at the RPE/choroid interface and contribute to the growth of sub-
RPE deposits.  
 
 
Results and Discussion 
As part of our ongoing studies to determine the composition of sub-RPE deposits(17, 18), we 
collected micro-focused synchrotron X-ray diffraction (µXRD) patterns from isolated sub-RPE 
deposits from human cadaver eyes. The µXRD pattern clearly identified hydroxyapatite (HAP) in 
sub-RPE deposits (Figure 1A and B), demonstrating that this highly insoluble form of calcium 
phosphate (Ca5(PO4)3OH, also called hydroxylapatite), ordinarily found in bones and teeth, is 
present in sub-RPE deposits. Ectopic calcification of soft tissues has been associated with the 
general  aging  process,  and  significant  calcification  of  the  collagenous  layer  of  Bruch’s 
membrane is typically present in AMD(19). This calcification can be readily labelled with Von 
Kossa's stain(20) that indicates the presence of calcium phosphates. However,  compared with 
other calcium phosphates, HAP is much less soluble, more stable, mechanically harder, and to 
our knowledge solubilized physiologically only with acid treatment(21). Small internal spherules 
with calcium content have been noted in sub-RPE deposits before(20, 22) but HAP has not 
been associated with these spherules. 
 
We  imaged  HAP  in  sub-RPE  deposits  in  human  cadaver  eyes  by  confocal  fluorescence 
microscopy using four stains  that are known to  label  HAP in  bones and teeth. These  were 
tetracycline(23)  and  its  analog  Bone-Tag  680  RD(24),  Alizarin  Red  S(25)  and  Xylenol 
Orange(26).  Three  of  these  compounds  have  differing  HAP-binding  moieties  (Supporting 
Information  FigureS1), making it unlikely that the very similar fluorescent staining with each 4 
 
 
compound was due to nonspecific binding to some other molecule(s), such as a protein.  These 
stains  are  specific  for  HAP  in  contrast  to  dibasic  calcium  or  zinc  phosphates  (Supporting 
Information Figure S2) and they all displayed very similar staining patterns in freshly dissected 
flat mounts of human cadaver retinas (Supporting Information Figure S3). Bone Tag 680 RD 
fluorescence (depicted as magenta in Figure 1C-D) and used in most of the experiments) was 
present  in  small  (0.5–20  µm  diameter,  average  size  ~3  µm)  spherules  within  all  sub-RPE 
deposits. This fluorescence was quite distinct from the typical tissue autofluorescence (depicted 
in green in Figure 1F-H) (27) or pigment granules.  The spherules typically exhibited a hollow 
appearance, indicating that the dyes did not stain the core of the spherules (Figure 1D-H).  This 
was  not  simply  a  consequence  of  poor  dye  penetration,  as  sectioned  specimens  with  HAP 
stained on the cut face appeared hollow as well (supplementary information Movie M1). The 
number of HAP spherules varied between sub-RPE deposits: in some there were only a few, in 
others there were dozens present (Figure 1D-F). In addition, we identified spherules that were 
not surrounded by the autofluorescence typical of sub-RPE deposits(27) (Figure 1G and H). 
Essentially identical spherules were observed in sub-RPE deposits in all of the 30 eyes from 
different donors we received in a 6 month period, with an age range of 43-96 years (Supporting 
Information Table T1).There was a direct relationship between the thickness of the sub-RPE 
deposits and the number and size of drusen on the one hand, and the number of HAP labeled 
spherules on the other. There were no obvious gender differences in the labeling, though there 
were variations in retinal location. Some eyes contained large, soft drusen-like deposits in the 
macula (Figure 1A, and labelled with *** in Table S1), suggesting that these donors had early 
AMD.  Large  areas  covered  by  diffuse  deposits  were  reminiscent  of  basal  laminar  or  linear 
deposits (Fig 1B). With our current light microscopy approach using unfixed tissues we were not 
able to unambiguously identify the different subtypes of sub-RPE deposits. However, all eyes 
contained hard drusen-like deposits mainly located at the retinal periphery (Figure 1C-D and 
Table 1, labelled with *). Spherules were occasionally seen in isolation in the sub-RPE space 
(Figure 1E-F). 
 
The similarity of form and hollow nature of the spherules raised the question of what may be in 
the center that promotes the formation of the HAP shell. Lipids are actively transported through 
the Bruch’s membrane(2, 10) and can be coated by HAP in vivo(28). Therefore, unfixed whole 
mount samples were stained with Nile Red, a fluorescent dye for neutral lipids. Nile Red labeled 
a large number of spherical inclusions with diameters similar to HAP spherules in these samples 
(Supporting Information  Figure S4). Unfortunately, double labeling with Nile Red and the 
HAP dyes was unsuccessful due to incompatibilities of the reagents. Therefore, we analysed 
the  composition  of  flat  mounted  and  freeze-dried  (Figure  2E)  sub-RPE  deposits  by  mass 
spectrometry  imaging.  For  this  experiment  sub-RPE  deposits  (a  druse  on  Figure  2)  were 
“milled” (without fixation or mechanical sectioning) using a focused ion beam (FIB) to reveal the 
inner  structure  of  the  druse  (Figure  2A  and  B)  while  preserving  the  native  chemical 
composition. The milled samples were then analysed with time-of-flight secondary ion mass 
spectrometry (TOF-SIMS), which is well suited to this investigation as it combines high lateral 
resolution (~250 nm) and high sensitivity(29), and images molecular ions and organic molecules 
over a wide mass range. A multivariate image analysis (non-negative matrix factorization score 
plot)  clearly  demonstrated  chemically distinct  spherular  structures inside the  drusen (Figure 
2F).  Further  analysis  of  selected  ions  provided  detailed  and  independent  maps  of  calcium 
phosphate (Figure 2C), organic molecules such as cholesterol (Figure 2D), ions characteristic 
of  phosphatidylcholine  (Figure  2G),  and  overall  protein  signature  (Figure  2H).  Neither  the 
readily-identified m/z 184 ion, derived from phosphocholine headgroups, nor those of protein 
signatures showed enrichment in spherules. The ionic signatures for other phospholipids and/or 
triglycerides were  not detected at this spatial resolution. However, the spherules in sub-RPE 5 
 
 
deposits clearly contain calcium phosphate (these experiments did not distinguish the different 
calcium phosphates) and they are also associated with cholesterol and/or cholesteryl esters in 
accord  with  previous  observations  on  the  composition  of  extracellular  lipid  droplets  in  the 
Bruch’s membrane and sub-RPE deposits (30, 31). 
 
The  shells  shown  in  Figure  1  are  strikingly  similar  to  images  previously  obtained  by  
immunohistochemical staining of proteins earlier identified as constituents of sub-RPE deposits, 
such as amyloid beta(15, 16), complement factor H (CFH)(32) and vitronectin(33). HAP is well 
known  to  bind  proteins  and  for  this  reason  is  widely  used  as  a  stationary  phase  for 
chromatography(34). Consequently we tested the hypothesis that the HAP spherules promote 
the growth of the protein-rich sub-RPE deposits by binding proteins present in the sub-RPE 
space.  Co-labelling  for  HAP  with  Bone-Tag  680  RD  and  antibodies  for  selected  proteins 
revealed a very distinct staining for each of amyloid beta, vitronectin, and complement factor H 
on the outer surface of the HAP spherules (Figure 2I,J,K, respectively). Triple labeling with 
amyloid beta (red), complement factor H (green) and HAP (magenta) shows that these proteins 
can  bind  to  the  same  HAP  spherule  simultaneously,  and  in  some  surface  areas  their 
immunostaining is so near to each other that they show co-localisation (yellow) (Figure 2L). Not 
all HAP spherules are positive for the tested proteins (Figure 2K and Supporting Information 
Figure  S5),  possibly  reflecting  localised  events,  such  as  site-specific  secretion  or  highly 
localised inflammatory reactions in a single cell. It is also interesting to note that while there is 
an enrichment of immunolabeling on the HAP surfaces for vitronectin (Figure 2G) this protein 
shows also a diffuse labeling around the spherules. Given that in these experiments we used 
whole mount immunolabeling and antibody penetration into all deposits equally could not be 
ascertained, quantification of the proportion of HAP spherules with the different antibodies was 
not  feasible.  Importantly,  HAP  spherules  are  present  in  some  cases  where  no  discernable 
protein deposit is present (as assessed by autofluorescence; Figure 1G,H), suggesting that 
HAP spherule formation may precede protein build-up and the consequent formation of this 
component of sub-RPE deposits. Moreover, the spherules described here differ overtly from the 
100  nm  matrix  vesicles  implicated  in  bone  formation,  which  have  distinct  crystals  of  HAP 
enclosed within a lipid shell(35). It is also important to note that immunostaining for several sub-
RPE deposit-associated proteins did not show a spherular staining pattern(36), and therefore it 
appears that there is a selectivity of protein binding to HAP.  
 
To elucidate further the selective binding of proteins to HAP, ARPE-19 cells (a widely used cell 
model for RPE studies) were grown in a stable-isotope-labeled amino acid-containing culture 
medium. Secreted proteins were bound to externally added magnetic HAP-coated beads; the 
same beads without HAP coating were used as controls. Bound proteins were identified by 
quantitative mass spectrometry-based proteomic analysis. The proteins in this complex mixture 
exhibited selective binding to HAP (Supporting Information Table T1) that included previously 
identified sub-RPE deposit-associated proteins (labelled red in Supporting Information Table 
T1):  Alpha  crystalline  B  (gene:  CRYAB),  Amyloid-like  protein  2  (APLP2),  glyceraldehyde-3-
phosphate dehydrogenase (GAPDH); histone H2A.x (H2AFX), proteasome subunit beta type 6 
(PSMB6),  and  vimentin  (VIM).  This  experiment  was  not  designed  to  exactly  replicate  the 
conditions in the aging retina in vivo, particularly since we did not culture cells until they were 
well differentiated, nor were the Bruch’s membrane and choroid present. Therefore we did not 
expect to identify all sub-RPE-associated proteins in this mixture as many would be secreted in 
very  small  quantities  from  “unchallenged”  RPE  cells.  Furthermore,  many  of  the  sub-RPE 
deposit-associated proteins originate from blood(7). This experiment was designed to show that 6 
 
 
proteins have different affinities to HAP and that several proteins actually do not bind to the HAP 
surface  under  these  conditions  (Supporting  Information  Table  T2).  Evidently,  HAP  can 
provide a surface for preferential binding and hence concentration of proteins, forming a scaffold 
for  more  extensive  and  less  specific  binding  of  proteins  and  can  lead  to  sub-RPE  deposit 
growth. 
 
Based on these observations we propose a novel mechanism for the growth, and perhaps the 
initiation, of sub-RPE deposits with implications for the development of AMD depicted in Figure 
3. Sub-RPE deposit growth, and maybe even formation, may be mediated, at least partly, by the 
formation of HAP shells on cholesterol-containing, naturally present extracellular lipid droplets at 
the RPE/choroid interface (Figure 3). This calcification process in drusen can be distinguished 
from that in atherosclerotic plaques(37, 38) where, instead ofextracellular lipid droplets, HAP is 
deposited on large cholesterol crystals. Whether the HAP deposition in the two diseases share 
similarities has yet to be determined, but it is interesting to note that there were suggestions that 
the  two  diseases  might  be  related  to  each  other  (39).  Furthermore,  the  micron  sized 
extracellular lipid droplets in the core of the HAP spherules in sub-RPE deposits are likely to 
differ from the smaller (<200 nm) lipoprotein particles described by Curcio et al. (11), therefore 
HAP spherule formation underneath the RPE appears to be a novel phenomenon. Once the 
HAP-coated  spherules  are  formed  they  have  the  capacity  to  bind  different  proteins  and  so 
provide nucleation sites for the growth of sub-RPE deposits by promoting further protein binding 
and lipid deposition and entrapment, leading to a self-driven oligomerisation process and the 
growth of sub-RPE deposits to clinically relevant size (Figure 3).  
Mild  to  moderate  calcification  of  the  elastic  layer  of  the  Bruch’s  membrane  is  commonly 
observed  in  aging  eyes(20)  and  can  be  a  sign  of  accelerated  aging(19).  Needle-like 
calcifications, presumed but not proven to be HAP, were described in the Bruch’s membrane in 
pseudoxanthoma elasticum(40); these however differ from the HAP spherules in location and 
morphology  (Supplementary  Figure  S6).  Classic  freeze-fracture  and  scanning  electron 
micrographs show calcium- and phosphorus-containing spherules similar in size to those shown 
in this study(41), but this has generally been interpreted as dibasic calcium phosphate and not 
as  HAP,  and  was  not  associated with the binding of proteins and the entrapment of lipids. 
Therefore, HAP spherule formation on the surface of lipid droplets in the inner aspect of the 
Bruch’s membrane is a newly recognized phenomenon that differs from previously described 
calcifications. Hydroxyapatite need not form as a result of a "maturing" process from previously 
deposited  amorphous  calcium  phosphate:  HAP  can  be  directly  formed  in  physiological 
concentrations of calcium and phosphate at physiological pH(42) and this appears to be the 
case for the sub-RPE space. We note that hydroxyapatite is much harder and less soluble than 
dibasic calcium phosphate, with the former only being re-solubilized by acid secretions in bone 
remodeling(43).  Interestingly,  calcified  drusen  are  usually  associated  with  end  stage  AMD 
(geographic atrophy) (44). It is known that drusen resolve as GA develops and it is possible that 
the calcific material represents HAP spherules that are resistant to clearing during this process. 
Sub-RPE deposit formation in the macula is the hallmark of AMD, but deposits are also present 
in the aging eye without recognized AMD, especially in the peripheral retina(18). Based on post 
mortem grading for AMD(45) we examined several eyes with sub-RPE deposits in the macula, 
and all these contained numerous HAP spherules. However a precise correlation with clinical 
characterization of drusen, such as hard and soft, could not be ascertained by examination of 
non-fixed  samples.  Therefore,  understanding  how  the  HAP  shells  form  on  the  ubiquitous 
cholesterol-containing droplets (9, 10) and how particular proteins bind to these surfaces and 
initiate the formation of sub-RPE deposits, will be key to improving our understanding of forms 
of AMD in which this process is important, and may lead to novel early intervention strategies, 
perhaps before sight-threatening conditions develop.  7 
 
 
Methods 
 
HAP Fluorescent Labeling and Immunohistochemistry of Deposit Proteins 
Thirty human eyes of donor ages between 43 and 96 years were obtained from the Moorfields 
Eye Hospital Eye Depository and were post mortem phenotyped based on the Alabama grading 
for post mortem tissues (45). Samples were obtained within 24 h of death. Full Local Research 
Ethics Committee approval and appropriate consent were obtained in each case. The protocol 
of the study adhered to the tenets of the Declaration of Helsinki regarding research involving 
human tissue. Flat mounts of Bruch’s membrane/choroid were prepared, after removal of the 
neurosensory retina and the RPE cells as described previously (27). It is important to note that 
none  of  the  samples  were  fixed  for  these  experiments  to  avoid  post-mortem  chemical 
interference. Of these samples, six had extensive sub-RPE deposits resembling soft drusen or 
basal  linear/laminar  deposits  when  examined  under  white  light  (Nikon  LMZ  1500  stereo 
microscope), a further 10 had numerous focal deposits (hard drusen) in the macula, while all 30 
had  manifested  peripheral,  mainly  focal,  sub-RPE  deposits  (in  Table  1  (*)  indicates  the 
presence  of  hard  drusen  while  (***)  indicates  extensive  focal  and/or  large  diffuse  sub-RPE 
deposits). Basal linear and laminar deposits could not be differentiated on whole mounts and, 
given the nature of the experiments and the incompatibilities of methodologies for resampling, 
unambiguous identification of the subtypes of sub-RPE deposits using electron microscopy was 
not possible(27). In some experiments fixed, paraffin-embedded samples were obtained from 
the  Pathology  Archive  at  the  UCL  Institute  of  Ophthalmology.  Based  on  pathology  reports 
describing the presence of different type of sub-RPE deposits in the macula or at the peripheral 
retina, suitable eyes were selected and 7 um sections were stained for HAP. 
Flat mounts were stained with 1 mg/ml Alizarin Red S (Sigma-Aldrich; Excitation wavelength: 
532 nm, Emission wavelength: 620 nm), 20 μM Bone-Tag 680RD (Li-Cor, Lincoln, Nebraska; 
Ex: 620 nm, Em: 680 nm), 1 mg/ml tetracycline (Sigma-Aldrich; Ex: 405 nm, Em: 570 nm) or 
1mg/ml Xylenol Orange (Sigma-Aldrich; Ex: 532 nm Em:570 nm) all in aqueous buffer for 20 
minutes at room temperature. Nile Red (Invitrogen; Ex: 532 nm, Em: 620 nm) was first dissolved 
in acetone and then diluted in aqueous buffer to 3.5 mg/ml and tissues were incubated for 20 
minutes at room temperature.  
Immunohistochemistry was also performed on unfixed flat mounted Bruch’s membrane/choroid 
tissue,  obtained  as  above.  Flat  mounts  were  blocked  with  goat  serum,  then  incubated  with 
primary and secondary antibodies for 2 hours each at 30 C. The primary antibodies used were 
anti-complement  factor  H  (Santa  Cruz;  1/100  dilution),  anti-vitronectin  (AbDSerotec,  1/200 
dilution) and anti-amyloid  (6E10, Covance, 1/100 dilution). Alexa-Fluor 488 Goat anti-rabbit 
and  Alexa-Fluor  568  Goat  anti  rat  secondary  antibodies  were  from  Invitrogen  and  used  in 
1/1000 dilution. Samples were imaged using a Zeiss LSM700 confocal microscope through a 
63x/1.2 NA Zeiss Neofluar objective.  
  
Mapping of Drusen Constituents by TOF-SIMS Imaging 
Flat mounts on glass slides were transported and stored at -20°C, then immediately prior to 
analysis were placed in a freeze dryer for four hours to ensure the samples were compatible 
with the ultra-high vacuum conditions of the SIMS instruments. In order to expose the internal 
structure of drusen, a focused ion beam (FIB) milling approach was implemented using an FEI 
FIB200-SIMS. Following gold sputter coating to ensure a conducting surface, the glass slide 
was mounted on the sample stage. Using an increased ion beam current, the upper 1μm was 
removed sequentially until the required region of the drusen was reached (Figure 2).  8 
 
 
 
For  mass  spectrometry  imaging  at  sub-micron  resolution  over  m/z  0-880,  the  slide  was 
immediately transferred to a TOF.SIMS 5 (ION-TOF, Münster, Germany) secondary ion mass 
spectrometer. The system comprises a bismuth primary ion beam, operating at 25 kV and tuned 
to use the Bi3
+ cluster for greater secondary ion yield, and a low energy electron flood gun for 
charge  compensation.  Ionic  species  sputtered  from  the  surface  under  the  bismuth 
bombardment are steered into a reflectron time-of-flight mass analyser. 
 
All data analysis and visualization was performed using in-house written MATLAB functions. 
Non-negative  matrix  factorization  was  performed  on  the  data  in  order  to  reduce  its 
dimensionality into five chemically distinct factors. Peaks identified as strongly localized to the 
spherules  were  identified  from  the  factors  and  single  ion  images  produced  (Figure  2).  The 
overall protein signature was based on summing a combination of characteristic immonium ions; 
the phosphatidylcholine  (PC)  distribution was visualized by the PC head-group peak at m/z 
184.07; and cholesterol by its [M+H-H2O]
+ion at m/z 369.38.  
 
Synchrotron µX-Ray DiffractionAnalysis of Drusen 
Synchrotron  micro-focused  X-ray  diffraction  analyses  (µXRD)  of  drusen  were  conducted  at 
beamline X26A, National Synchrotron Light Source, Brookhaven National Laboratory, Upton, 
NY USA. Tissue samples containing drusen were flat mounted on 4µm thick Ultralene
® film for 
analysis.  Monochromatic  X-rays  were  used  tuned  to  an  incident  wavelength  of  0.70926  Å, 
corresponding to 17.481 keV energy, using a channel-cut Si(111) monochromator crystal. The 
incident beam was focused to a spot size of 9 (H) x 5 (V) µm on the sample using Rh-coated 
silicon  mirrors  in  a  Kirkpatrick-Baez  geometry.  The  X-ray  diffraction  from  the  sample  was 
measured using a Rayonix SX165 CCD area detector. Calibrations and corrections for detector 
distortions  (camera–sample  distance,  camera  tilt  and  rotation,  and  the  beam  center  on  the 
camera plane) were done using Fit2D™ software (46) and corrected using NIST SRM 674a 
corundum standard and silver behenate. The 2D area detector data was integrated in to 2 -
intensity  using  Fit2D  and  HAP  was  then  identified  by  comparison  with  reference  powder-
diffraction patterns (ICDD 2003) using the Match software (Crystal Impact). 
 
Identification of HAP-Bound Proteins Secreted from Cultured RPE Cells by SILAC 
Cell culture For stable isotope labeling with amino acids in cell culture (SILAC) experiments, 
ARPE-19  cells  were  grown  in  SILAC  DMEM:F12  medium  (PAA)  supplemented  with  10% 
dialyzed fetal bovine serum (PAA), 1% (v/v) penicillin-streptomycin and 
12C6,
14N2 lysine plus 
12C6,
14N4 arginine (light medium) or 
13C6 lysine plus 
13C6,
15N4 arginine (heavy medium). 0.5 mM 
proline was added to all SILAC media to prevent arginine-to-proline conversion(47). All amino 
acids were purchased from Silantes. Sub-confluent cultures were thoroughly washed with PBS 
and kept in serum-free medium for 24 hours. Label-swap replication was used for enhanced 
reliability in affinity ratios. Equal amounts of “heavy” supernatants were incubated either with 
BcMag
TM hydroxyapatite-coated magnetic silica beads (Bioclone, San Diego) or with unmodified 
silica beads (negative control). “Light” supernatants were processed in the same way. After 
incubating  three  hours  on  a  rotator  at  25°C,  bound  proteins  were  washed  with  serum/free 
medium (2X 15 min). Finally, the beads were re-suspended in 30 µl of 50 mmol/L ammonium 
bicarbonate  (ABC)  and  subjected  to  on-bead  tryptic  digestion.  The  corresponding  samples 9 
 
 
(eluates from light-labeled HAP and heavy-labeled control beads, and vice versa) were mixed 
as described earlier(48) before being subjected to LC-MS/MS. 
Mass spectrometry and data analysis LC-MS/MS analysis was performed on an Ultimate3000 
nano HPLC system (Dionex) coupled to a LTQ OrbitrapXL mass spectrometer (Thermo Fisher 
Scientific, Waltham, USA) by a nano spray ion source. For SILAC experiments, all acquired 
spectra were processed and analyzed using MaxQuant  version 1.3.0.5  (www.maxquant.org) 
and  the  human-specific  SwissProt  (http://www.maxquant.org/)  in  combination  with  Mascot 
(version  2.2;  Matrix  Science).  Cysteine  carbamidomethylation  was  selected  as  fixed 
modification;  methionine  oxidation  and  protein  acetylation  were  allowed  as  variable 
modifications. The peptide and protein false discovery rates were set to 1%. Contaminants like 
keratins were removed. Proteins identified and quantified by at least 2 peptides per experiment 
were considered for further analysis. Each experiment consisted of a forward and a reverse 
labeling approach (label swapping) to exclude label-specific effects. A P value of 0.001 was 
selected as threshold for significant enrichment or alteration. 
 
Study approval.  
 
Thirty human eyes with sub-RPE deposits were obtained from the Moorfields Eye Hospital Eye 
Depositorywithin24 h of death. Full Local Research Ethics Committee approval and appropriate 
consent was obtained in each case. The protocol of the study adhered to the tenets of the 
Declaration of Helsinki regarding research involving human tissue. 
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Figure 1:  
 
Hydroxyapatite (HAP) is present in sub-RPE deposits as spherular structures. X-ray diffraction 
pattern (A) and radial intensity profile (B) confirmed the presence of hydroxyapatite in isolated 
sub-RPE deposits. Red lines in B indicate the position of diffraction peaks for pure HAP powder. 
Deposits contain numerous HAP spherules(magenta, stained with Bone Tag 680RD) in sub-
RPE  deposits(C-F).Optical  sectioning  using  confocal  microscopy  revealed  that  HAP  forms 
spherules throughout macular large drusen (D) as well as in hard drusen (E and F), but were 
also  seen  in  the  absence  of  the  typical  autofluorescence  (green)  of  sub-RPE  deposits  and 
Bruch’s membrane (G and H).   
 
Figure 2:  
 
Identification of molecular constituents of the inner core and outer surface of HAP spherules by 
TOF-SIMS. Secondary electron (A) and secondary ion (B) images of the inner structures after 
FIB  millingof  a  deposit  (E).The  non-negative  matrix  factorisation  score  plot  demonstrates 
chemically distinct spherules (F) inside the deposit. Positive ion SIMS images confirmed the 
selective enrichment of calcium phosphate (C) and cholesterol (D), but not phosphatidylcholine 
head-group  (G)  or  combined  signals  from  protein  fragments  (H)  associated  with  the  HAP 
spherules. Immunohistochemical fluorescent labeling with protein-specific antibodies revealed 
that HAP spherules (magenta on fig I-L) were found coated with amyloid beta (I, red), vitronectin 
(J, yellow), complement factor H (K, green), or co-labeled by a combination of these proteins (L, 
red:amyloid  beta;  green:complement  factor  H).  Not  all  the  spherules  are  labelled  by  the 
antibodiesused (L and K) indicating diverse protein binding to HAP spherules. Scale bars are10 
µm on panels A-H, and 2 µm on panels I-L. 
 
Figure3:  
 
A simplified diagram of the proposed mechanism for the growth of sub-RPE deposit. Deposit 
growth is associated with, maybe even initiated by, the precipitation of HAP (magenta) onto the 
naturally  present,  micron  sized  cholesterol-containing  extracellular  lipid  droplets  (black). 
Consequently  different  proteins  (blue)  bind  to  the  HAP  surface,  which  facilitates  further 
deposition in a self-driven oligomerisation process, leading ultimately to the formation of the 
macroscopic sub-RPE deposits (yellow). Melanocytes are depicted as brown particles in the 
RPE.  
 